Elmiron Warning Label Risk of Pigmentary Maculopathy скачать в хорошем качестве

Elmiron Warning Label Risk of Pigmentary Maculopathy

Doctors prescribe Elmiron to treat the symptoms of Interstitial Cystitis, also called "painful bladder syndrome." Many of the patients who take Elmiron, do so for years. Some patients reported vision problems within the first year of taking the drug, but most vision problems occurred after three years. According to research studies, taking Elmiron can cause maculopathy, resulting in changes in vision, loss of vision, and blindness. A number ofpatients who have experienced vision loss and other eye injuries have filed lawsuits against the makers of Elmiron, Janssen Pharmaceuticals. In these lawsuits, the victims allege that Janssen's failure to warn that Elmiron could cause blindness was negligent. The victims are seeking compensation from the makers of this dangerous drug. NEW LABEL WARNS THAT ELMIRON MIGHT CAUSE PIGMENTARY MACULOPATHY The label notifies patients that taking Elmiron might result in retinal changes that could lead to vision loss and changes. It also tells patients that the risk of developing problems might increase, the longer they take Elmiron. Interestingly, the label also advises doctors to get patients' "ophthalmologic history" before prescribing Elmiron. It also suggests conducting baseline retinal tests, and periodic follow up tests to determine if problems develop or worsen after starting Elmiron. The warning also lets patients know that vision problems can continue to progress after they stop taking Elmiron. Don't delay. The team at Alonso Krangle continues to take on new cases, and may be able to help you. Call today or visit FightForVictims.com https://fightforvictims.com/blog/elmi... ~~~~~~~~~~ If you believe you or a family member has been impacted by RoundUp or any other dangerous medication or product, call Alonso Krangle today at 800-403-6191 or visit https://FightForVictims.com #elmiron #maculopathy #fda #labelchange